Chapter 13 - Other organ involvement and clinical aspects of Wilson disease
Introduction
Wilson disease (WD) is known for its diverse clinical symptoms and signs, but it typically presents with hepatic and neuropsychiatric features due to copper accumulation in the liver and brain. However, copper also accumulates in other organs and may cause other manifestations of WD.
Very high copper content is detected in the kidneys of WD patients. In 8 untreated patients described by (Scheinberg and Sternlieb, 1984), the copper concentration in the kidneys was very high compared to a control group (904 μg/g dry tissue vs. 15 μg/g dry tissue). The copper content in the hearts of WD patients is also higher (average 157 μg/g dry tissue) than in healthy people (average 17 μg/g dry tissue). Increased copper concentrations have also been detected in the bones of WD patients (5.5 μg/g wet tissue vs. 0.8 μg/g wet tissue), and copper deposition has been reported in cartilage biopsies from WD patients (Menerey et al., 1988). In addition, 1 out of 5 WD patients has an increased copper concentration in the pancreas (Scheinberg and Sternlieb, 1984).
In this chapter we will discuss the various less typical, but still important, clinical features of WD, which may be caused by copper toxicity but may also be sequels of liver disease or anticopper therapy. For management of some of the other organ symptoms, see also Chapter 17.
Section snippets
The kidneys
In WD, excess copper is eliminated by the kidneys, resulting in increased urinary copper excretion (Scheinberg and Sternlieb, 1984, European Association for the Study of the Liver, 2012). As with the liver and brain, copper accumulates in the kidneys and may impair renal function.
Normal urinary copper excretion is < 50 μg/24 hours. In patients with WD, copper excretion is often > 100 μg/24 hours (EASL, 2012). Increased urinary excretion is also detected in primary biliary cirrhosis, hepatitis,
The osteoarticular system
Osteoarticular manifestations are a common feature of WD and mainly involve osteopenia, osteoporosis, and arthropathy (Warnock, 1952, Feller and Schmuacher, 1972, Kaklamanis and Spengos, 1973, Golding and Walshe, 1977, Lugassy et al., 1988). Bone demineralization is frequently observed in WD patients and possibly results from hypercalciuria and hyperphosphaturia. Joint problems may be caused by copper deposition (Canelas et al., 1978, Menerey et al., 1988). Osteoporosis may also result from
Cardiovascular system
Another manifestation of WD is cardiac involvement, including arrhythmias, cardiomyopathy, and autonomic dysfunction. However, this manifestation rarely results in clinical problems. The average copper content in the heart is much higher in WD patients (157 μg/g dry tissue) than in healthy people (17 μg/g dry tissue) (Scheinberg and Sternlieb, 1984). Myocardial copper accumulation may cause cardiomyopathy and arrhythmias (Factor et al., 1982, Kuan, 1982). The number of studies evaluating the
Endocrinology
The endocrine manifestations of WD may include disorders of growth and puberty, hypothyroidism, hypoparathyroidism, infertility, or repeated miscarriages (Frydman et al., 1991, Sinha et al., 2004, Leggio et al., 2007, European Association for the Study of the Liver, 2012). The frequency of endocrinologic manifestation is difficult to establish because single cases have mainly been reported (Klee, 1979, Krysiak et al., 2012).
The most common cause of gonadal dysfunction in patients with WD is
Hematology
Hematologic symptoms include acute Coombs-negative hemolytic anemia, leukopenia, anemia, and thrombocytopenia (EASL, 2012). Acute Coombs-negative hemolytic anemia with hemolytic jaundice may be an initial symptom of WD in 10–15% of patients (Yarze et al., 1992) and precede the onset of neurologic or hepatic symptoms (Hoogenraad, 1996). Among 276 cases, 19 (6.8%) had hemolytic anemia confirmed by laboratory tests at admission. However, in a group of patients presenting with jaundice, 28% also
Dermatology
Dermatologic signs in WD include those that occur during the course of disease as well as complications after DPA treatment. Skin changes may occur as result of liver cirrhosis and involve mainly vascular spiders and palmar erythema (Wiliam et al., 2011). Cutaneous findings in WD include hyperpigmentation of the lower extremities (Fig. 13.4), azure lunulae (“sky-blue moon”) (Fig. 13.5) of the nails, anetoderma, xerosis, acatnosis nigricans, and dermatomyositis (Wiliam et al., 2011, Ivanova et
Lipomas
As we observe at our center, WD patients often present with lipomas (Fig. 13.6). Schaefer et al. (2015a) reported a high frequency of subcutaneous lipomas in a cohort of WD patients; among 80 patients with WD, lipomas were found in 26% during examination. Multiple subcutaneous lipomas were noted in 16 (76%) of the 21 affected patients. Lipomas were present mainly on the trunk and extremities. Histologic examination was performed in 3 patients and revealed typical lipoma tissue. Neither initial
References (124)
A study of haemolysis in Wilson's disease
J Neurol Sci
(1972)- et al.
Immunological observations on patients with Wilson's disease
J Neurol Sci
(1976) - et al.
Hepatic osteodystrophy. Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease
Gastroenterology
(1989) - et al.
Pancreatic distortion due to splenomegaly in Wilson's disease
Lancet
(1983) - et al.
Symptomatic copper deficiency in three Wilson's disease patients treated with zinc sulphate
Neurol Neurochir Pol
(2014) EASL clinical practice guidelines: Wilson's disease
J Hepatol
(2012)- et al.
Copper toxicity, oxidative stress, and antioxidant nutrients
Toxicology
(2003) - et al.
Ultrastructure of penicillamine induced skin lesions
J Am Acad Dermatol
(1981) - et al.
Endocrine studies of the ovulatory disturbances in Wilson's disease (hepatolenticular degeneration)
Fertil Steril
(1987) Undiagnosed Wilson's disease as cause of unexplained miscarriage
Lancet
(1979)
Fatal cardiac complications of Wilson's disease
Am Heart J
Cardiac Wilson's disease
Chest
Congenital scoliosis in Wilson's disease: case report and review of the literature
BMC Surg
Pancreatic enlargement and Wilson's disease
Lancet
Wilson's disease presenting as symptomatic urolithiasis: a case report and review of the literature
J Urol
Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson disease
Am J Gastroenterol
Collagen cross-linking. Effect of D-penicillamine on cross-linking in vitro
J Biol Chem
Successful pregnanacies and abortions in symptomatic and asymptomatic Wilson's disease
J Neurol Sci
Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance
J Hepatol
D-penicillamine-induced elastosis perforans serpiginosa and localized cutis laxa in a patient with Wilson's disease
Isr J Med Sci
P wave dispersion is prolonged in patients with Wilson's disease
World J Gastroenterol
Erythrocyte metabolism and antioxidant status of patients with Wilson disease with hemolytic anemia
Pediatr Res
D-penicillamine elastosis perforans serpiginosa: description of two cases and review of the literature
Dermatol Online J
Hypercalciuria and nephrolithiasis as a presenting sign in Wilson's disease
Eur J Pediatr
“Lumpy-bumpy” elastic fibers in the skin and lungs of a patient with a penicillamine-induced elastosis perforans serpiginosa
J Cutan Pathol
Renal function in Wilson's disease
J Clin Invest
Trientine induced colitis during therapy for Wilson disease: a case report and review of the literature
BMC Pharmacol Toxicol
Autonomic dysfunction in Wilson's disease
Clin Auton Res
Osteoarthropathy of hepatolenticular degeneration
Acta Neurol Scand
Renal and circulatory dysfunction in liver cirrhosis. Pathogenesis and treatment
Ann Gastroenterol
Hypoparathyroidism in Wilson's disease
N Engl J Med
Studies on copper metabolism. XIII. Hepatolenticular degeneration
J Clin Invest
Copper deficiency in Wilson's disease: peripheral neuropathy and myelodysplastic syndrome complicating zinc treatment
Mov Disord
Myastenia syndrome during penicillamine treatment
Brit Med J
The influence of prolonged treatment with d-penicillamine on the immune response in Wilson's disease
Europ J Clin Pharmacol
Clinical features of hemolysis, elevated liver enzymes and low platelet count syndrome in undiagnosed Wilson disease: report of two cases
Arch Gynecol Obstet
D-penicillamine versus zinc sulfate as first-line therapy for Wilson's disease
Eur J Neurol
Effect of penicillamine on the kidney
Proc R Soc Med
Hemolytic anemia in Wilson's disease
Ann Intern Med
Hypercalciuria and nephrocalcinosis as early feature of Wilson disease onset: description of a pediatric case and literature review
Hepatitis Monthly
Idiopathic thrombocytopenia associated with Wilson's disease
Hepatogastroenterology
Subclinical diastolic dysfunction in children with Wilson's disease assesses by tissue Doppler echocadrography: a possible early predictor of cardiac involvement
Acta Cardiol
The cardiomyopathy of Wilson's disease: myocardial alteration in nine cases
Virchow's Arch A Pathol Anat
Cutaneous side effects of D-penicillamine
Indian J Dermatol Venereol Leprol
Osteoaricular changes in Wilson's disease
Arthritis Rheum
Diagnosis and phenotypic classification of Wilson disease
Liver Int
Hemolytic anemia in Wilson disease: clinical findings and biochemical mechanisms
Am J Hematol
Axonal sensory motor neuropathy in copper-deficient Wilson's disease
Muscle Nerve
Urinary copper excretion and hepatic copper concentrations in liver disease
Digestion
Assessment of the hypothalamic-pituitary-testicular function in male patients with Wilson's disease
J Androl
Cited by (30)
Wilson's disease: Is it time to leave behind old clichés?
2023, Parkinsonism and Related DisordersCase study on acupuncture treatment for Wilson disease
2022, World Journal of Acupuncture - MoxibustionWilson's disease- management and long term outcomes
2022, Best Practice and Research: Clinical GastroenterologyCitation Excerpt :As these symptoms are not typical for WD and often need to anti-copper treatment breaks, the awareness between psychiatrists as well as additional symptomatic psychiatric treatment of WD are very important [13]. Other clinical symptoms are less common, are due to multi-organ damage due to copper accumulation and include renal, cardiac, skin, osteoarticular as well as endocrinological symptoms [14]. Diagnosis of WD may cause difficulties as it should combine several tests, and the basic tests-ceruloplasmin levels and urinary copper excretion can be normal.
Skin manifestations associated with systemic diseases – Part II
2021, Anais Brasileiros de DermatologiaCitation Excerpt :Mucocutaneous manifestations may occur as a result of this deposition, secondary to treatment with D-penicillamine or as a consequence of liver cirrhosis. The most described alterations are distal hyperpigmentation on the lower limbs, blue lunula, and Kayser–Fleischer rings (pigmentation circle in the periphery of the cornea).27 D-penicillamine, a drug used to treat Wilson's disease, can alter collagen biosynthesis.
Disorders of calcium metabolism
2020, Handbook of Diagnostic Endocrinologyhttps://www.elsevier.com/books/wilson-disease/heinz-weiss/978-0-12-811077-5
2019, Wilson Disease: Pathogenesis, Molecular Mechanisms, Diagnosis, Treatment and Monitoring